American Well Corporation (NYSE:AMWL) Q1 2022 Earnings Conference Call May 9, 2022 5:00 PM ET
Company Participants
Sue Dooley - Head Of Investor Relations
Ido Schoenberg - Chairman & co-Chief Executive Officer
Bob Shepardson - Chief Financial Officer
Conference Call Participants
Charles Rhyee - Cowen
Cindy Motz - Goldman Sachs
Stephen Baxter - Wells Fargo
Jessica Tassan - Piper Sandler
David Larsen - BTIG
Eric Percher - Nephron Research
Allen Lutz - Bank of America
Operator
Good afternoon, and welcome to Amwell's First Quarter 2022 Conference Call. Today’s call is being recorded. All lines have been place on mute. [Operator Instructions]
At this time, I would like to turn the conference over to Sue Dooley, Head Of Investor Relations. Please go ahead.
Sue Dooley
Hell, everyone, welcome to Amwell’s conference call to discuss our first fiscal quarter of 2022. This is Sue Dooley of Amwell, Investor Relations.
Joining me today are Amwell's, Chairman and co-Chief Executive Officer, Dr. Ido Schoenberg; and Bob Shepardson, our Chief Financial Officer.
Early today, we distributed a press release detailing our announcement. The release is posted on our website at investrs.amwell.com and it’s also available from normal new sources. This conference call is being website live on the Investor Relation page of our website where a reply will be archived.
Before we begin our prepared remarks, I would like to take this opportunity to remain during the course of this call, will make forward looking statements regarding projected operating results. And anticipate as market opportunities. This forward looking information is subject to the risk and uncertainties described in analyst filings with the SEC and actual results or events, may different materially. Except as required by law, we undertake no obligation to update or revise this forward looking statement.
On this call, we will refer to both GAAP and non-GAAP financial measurements. A reconciliation of GAAP to non-GAAP financial measures is provided in our posted earnings release.
With that, I will now turn the call over to Ido for his prepared remarks on the quarter. Ido?
Ido Schoenberg
Thanks, Sue, and welcome everyone. Q1 was an important quarter for our company as we continue to make progress on the launch of Converge our integrated technology platform that empowers and complements leading health care organizations as their pursue business initiatives in a fragmented and rapidly changing digital care delivery landscape.
We are proceeding according to our plan for this year and our teams are engaged and inspired by the benefits of clarity of purpose and well-defined role in a digital-first future. I'll start by reviewing some highlights of the quarter and the full year. Then I'll take a moment to discuss the market for our solution and the key benefits assigned to patients providers, payers and innovators. Bob will then review some key metrics, our financial results and our guidance.